India’s production of affordable generic medicines sustains a global lifeline, but it must fortify quality assurance

Strengthening quality assurance at the time of approval of medicines at the State level and endorsing a pro-public health patent system will be crucial to sustain India’s ability to supply quality, affordable medicines worldwide
India’s production of affordable generic medicines sustains a global lifeline, but it must fortify quality assurance
Leena Menghaney

Leena Menghaney is a lawyer with two decades of experience in public health, medicines law & policy

Published on
Loading content, please wait...

Related Stories

No stories found.
The Leaflet
theleaflet.in